14.62
전일 마감가:
$14.47
열려 있는:
$14.52
하루 거래량:
1.12M
Relative Volume:
0.85
시가총액:
$1.35B
수익:
$2.98B
순이익/손실:
$-300.00M
주가수익비율:
-4.30
EPS:
-3.4
순현금흐름:
$225.00M
1주 성능:
+14.63%
1개월 성능:
+21.92%
6개월 성능:
+184.57%
1년 성능:
-38.18%
Fortrea Holdings Inc Stock (FTRE) Company Profile
명칭
Fortrea Holdings Inc
전화
877-495-0816
주소
8 MOORE DRIVE, DURHAM
FTRE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
FTRE
Fortrea Holdings Inc
|
14.61 | 1.34B | 2.98B | -300.00M | 225.00M | -3.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.06 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
723.23 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
457.07 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
898.80 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.84 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Fortrea Holdings Inc Stock (FTRE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-04 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2025-05-02 | 개시 | Truist | Hold |
| 2025-04-10 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2024-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-12-06 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-09-25 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-08-08 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2024-07-24 | 재개 | Barclays | Equal Weight |
| 2024-06-06 | 개시 | Goldman | Neutral |
| 2024-05-29 | 개시 | TD Cowen | Hold |
| 2024-05-28 | 개시 | Mizuho | Neutral |
| 2024-03-22 | 개시 | Robert W. Baird | Neutral |
| 2024-03-06 | 개시 | Deutsche Bank | Hold |
| 2024-01-05 | 개시 | William Blair | Mkt Perform |
| 2024-01-04 | 개시 | Jefferies | Buy |
| 2023-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-12-01 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-11-14 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2023-10-19 | 개시 | Citigroup | Neutral |
| 2023-09-14 | 개시 | Evercore ISI | In-line |
| 2023-08-16 | 개시 | Barclays | Equal Weight |
| 2023-08-07 | 개시 | BofA Securities | Underperform |
모두보기
Fortrea Holdings Inc 주식(FTRE)의 최신 뉴스
Fortrea (NASDAQ:FTRE) Stock Price Down 5.7%Time to Sell? - MarketBeat
Fortrea, SCTbio announce strategic collaboration agreement - MSN
How Fortrea Holdings Inc. (K67) stock compares with market leadersMarket Sentiment Report & Technical Pattern Alert System - Newser
What dividend safety score for Fortrea Holdings Inc. stockPortfolio Return Report & Low Risk High Win Rate Picks - Newser
Fortrea Holdings Inc. (NASDAQ:FTRE) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Will Fortrea Holdings Inc. (K67) stock outperform global peersJuly 2025 Decliners & Reliable Volume Spike Trade Alerts - Newser
Fortrea (NASDAQ:FTRE) Shares Up 10.1%Time to Buy? - MarketBeat
SCTbio and Fortrea forge strategic collaboration to accelerate cell and gene therapy development and delivery - MarketScreener
Fortrea, SCTbio Collaborate Over Cell, Gene Therapy Development, Delivery - marketscreener.com
Fortrea (FTRE) and SCTbio team up to speed cell and gene therapy development - Stock Titan
Geode Capital Management LLC Increases Stake in Fortrea Holdings Inc. $FTRE - MarketBeat
Fortrea (FTRE) Valuation Check After Investigation into Alleged Overstated Revenue, Cost Savings, and 2025 EBITDA Targets - Yahoo Finance
Improved Revenues Required Before Fortrea Holdings Inc. (NASDAQ:FTRE) Stock's 26% Jump Looks Justified - 富途牛牛
Brandes Investment Partners LP Acquires 94,448 Shares of Fortrea Holdings Inc. $FTRE - MarketBeat
Is Fortrea Holdings Inc. stock trading at a premium valuationJuly 2025 Gainers & Weekly Return Optimization Alerts - Newser
Fortrea (FTRE) Valuation Check as Legal Probe Questions Revenue Recognition and 2025 EBITDA Targets - simplywall.st
Levi & Korsinsky Notifies Fortrea Holdings Inc. (FTRE) Investors - The National Law Review
Why (FTRE) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com
Transcript : Fortrea Holdings Inc. Presents at Citi Annual Global Healthcare Conference 2025, Dec-02-2025 01 - marketscreener.com
Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Unicycive Therapeutics, Inc. (NASDAQ: UNCY); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office is Investigating Claims on Your Behalf - GlobeNewswire Inc.
Will Fortrea Holdings Inc. (K67) stock benefit from sector leadership2025 Big Picture & Low Risk Entry Point Tips - Newser
SG Americas Securities LLC Reduces Position in Fortrea Holdings Inc. $FTRE - MarketBeat
How strong is Fortrea Holdings Inc. stock revenue growthTrade Exit Summary & Real-Time Buy Zone Alerts - Newser
Important Notice to Long-Term Shareholders of Cytokinetics, - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Fortrea Holdi - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Is Investigating Fortrea Holdings, Inc. (FTRE) And Encourages Stockholders to Connect - ACCESS Newswire
Is Fortrea Holdings Inc. stock a safe haven assetCEO Change & Detailed Earnings Play Strategies - BỘ NỘI VỤ
Envestnet Asset Management Inc. Sells 69,467 Shares of Fortrea Holdings Inc. $FTRE - MarketBeat
Fortrea Holdings, Inc. (FTRE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Can Fortrea Holdings Inc. stock maintain growth trajectory2025 Fundamental Recap & AI Enhanced Trading Signals - BỘ NỘI VỤ
Fortrea (NASDAQ:FTRE) Stock Price Up 7.4%What's Next? - MarketBeat
ProShare Advisors LLC Makes New $117,000 Investment in Fortrea Holdings Inc. $FTRE - MarketBeat
Does Fortrea’s (FTRE) Debt Buyback Mark a Shift in Its Post-Divestiture Financial Strategy? - Yahoo Finance
Fortrea Holdings (NASDAQ:FTRE) Nasdaq Futures Mirror Biotech Shifts - Kalkine Media
Fortrea completes $75.7M senior notes tender offer - MSN
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fortrea Holdings, Inc. (FTRE) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Fortrea Stock Gains on Debt RepurchaseFinancial Update 2025News and Statistics - IndexBox
Fortrea (FTRE) Stock Trades Up, Here Is Why - TradingView
Fortrea (Nasdaq: FTRE) to Join Citi and Evercore Healthcare Investor Conferences - Stock Titan
BrightSpring Health Services, 10x Genomics, QuidelOrtho, Medpace, and Fortrea Shares Are Soaring, What You Need To Know - Barchart.com
FTRE Form 4 shows director award of 20,916 restricted stock units - Stock Titan
Fortrea completes debt tender offer, reducing outstanding notes By Investing.com - Investing.com Nigeria
Fortrea Completes $75.7 Million Senior Notes Tender Offer Utilizing Cash on Hand - MarketScreener
Attention Long-Term Shareholders of Fortrea Holdings, Inc. (NASDAQ: FTRE); enCore Energy Corp. (NASDAQ: EU); Humana Inc. (NYSE: HUM); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf - GlobeNewswire
Fortrea Completes Repurchase of $75.7 Million of Senior Notes - MarketScreener
Fortrea completes $75.7 million senior notes tender offer utilizing cash on hand - MarketScreener
Fortrea completes debt tender offer, reducing outstanding notes - Investing.com
Fortrea (Nasdaq: FTRE) repurchases $75.7M notes, trimming outstanding issue to $494.3M - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Encourages Fortrea Holdings, Inc. (FTRE) Investors to Inquire about Securities Investigation - ACCESS Newswire
NeoGenomics, Fortrea, and Acadia Healthcare Shares Skyrocket, What You Need To Know - Yahoo Finance
Understanding Momentum Shifts in (FTRE) - news.stocktradersdaily.com
Fortrea Holdings Inc (FTRE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Fortrea Holdings Inc 주식 (FTRE) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Parks Robert | Chief Accounting Officer |
Sep 16 '25 |
Sale |
9.95 |
7,338 |
73,013 |
19,046 |
자본화:
|
볼륨(24시간):